Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.

Erratum

After the publication of this work [1], a few points were brought to our attention:

The clinical data of patient 2 are incorrect. A revised version of Table 1 [1] showing the corrected patient characteristics is presented here. Consequently, the description of the patient cohort in the Materials and Methods section is incorrect. The correct description is: “Plasma miRNA analysis was performed on 18 HNSCC patients treated with local X-ray-irradiation using a linear accelerator […].

Table 1

Patient characteristics

Characteristic	Number of patients
Gender
Male	14
Female	4
Median age, years	57.5
Age range, years	45.1–80.6
Tumor site
Larynx	5
Oropharynx	3
Mouth floor	2
Tongue	2
Hypopharynx	1
Maxilla	1
Nasopharynx	1
Sinuses	1
Soft palate	2
T-Stage
I	4
II	3
III	5
IV	6
N-Stage
N0	3
N1	4
N2	11
M-Stage
M0	17
M1	1
Concomitant therapy (in addition to radiotherapy)
5-FU + MMC	13 (patient 2, 3, 5–7, 9–13, 15–17)
MMC	3 (patient 1, 14, 18)
Cisplatin	1 (patient 8)
Cetuximab	1 (patient 4)
Acute toxicity
Severe	12
Moderate	5
n.a.	1

5-FU = 5-fluorouracil; MMC = mitomycin C; n.a. = not available.

17 out of 18 patients received concurrent chemotherapy (13 patients received 5-fluorouracil (5-FU) plus mitomycin C (MMC) [21], 3 patients MMC and 1 patient cisplatin weekly)”.

There is a typing error in the Results section [1] concerning the p value of the up-regulation of miR-425-5p. The correct sentence is:

“The qRTPCR assays confirmed an up-regulation of miR-425-5p with a p value close to the significance level (p = 0.052) […]”.

The corrections do not affect any results or conclusions of the published work.